Equities Research Analysts’ updated eps estimates for Tuesday, October 24th:

BMO Capital Markets assumed coverage on shares of Albemarle Corporation (NYSE:ALB). The firm issued an outperform rating on the stock.

Cantor Fitzgerald initiated coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX). Cantor Fitzgerald issued an overweight rating on the stock.

Alexion Pharmaceuticals (NASDAQ:ALXN) had its price target raised by Royal Bank Of Canada to $166.00.

American Woodmark Corporation (NASDAQ:AMWD) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “AMERICAN WOODMARK CORP. manufactures and distributes kitchen cabinets and vanities for the remodeling and new home construction markets. Co. currently offers framed stock cabinets in almost 100 different cabinet lines, ranging in price from relatively inexpensive to medium priced styles. Styles vary by design and color from natural wood finishes to low- pressure laminate surfaces. The entire product offering includes thirty-three door designs and five colors. “

Anthera Pharmaceuticals (NASDAQ:ANTH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company’s clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren’s Syndrome, Graves’ Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California. “

AeroVironment (NASDAQ:AVAV) had its hold rating reissued by analysts at Robert W. Baird. The firm currently has a $35.00 target price on the stock.

Baker Hughes, a GE company Class A (NASDAQ:BHGE) had its hold rating reissued by analysts at Piper Jaffray Companies.

Berkshire Hills Bancorp (NYSE:BHLB) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Berkshire Hills Bancorp, Inc. is a bank holding company. Through its subsidiaries, the company is engaged as a community bank that accepts retail deposits from the general public in the areas surrounding its full-service banking offices and uses those funds,together with funds generated from operations and borrowings, to originate residential mortgage loans, commercial business and real estate loans and consumer loans, primarily indirect automobile loans. “

Biogen (NASDAQ:BIIB) had its hold rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $279.00 price target on the stock. The analysts wrote, “MS franchise appears poised for modest negative growth. A tepid patient population growth rate combined with encroaching competition from new agents means existing franchise assets may have achieved peak revenues already, in our opinion.””

Bank of Hawaii Corporation (NYSE:BOH) had its hold rating reaffirmed by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $90.50 price target on the stock.

Banco Santander-Chile (NASDAQ:BSAC) was downgraded by analysts at Scotia Howard Weill from an outperform rating to a sector perform rating.

Coca-Cola Amatil (OTCMKTS:CCLAY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Coca-Cola Amatil limited’s principal activity is the manufacture, distribution and marketing of non-alcoholic ready to drink beverages which include carbonated and non carbonated drinks which include mineral and bottled waters, ready-to-drink coffee and tea, juices/nectar, sport drinks, fruit still drinks, energy drinks, other ready-to-drink beverages and flavoured milk drinks. Major brands include Coca-Cola, diet Coke, Coca-Cola Light, Fanta, Sprite, Lift, Lift Plus, POWERaDE, Mount Franklin, Fruitopia, pump, L&P, Deep Spring, Schweppes, Qoo, Kin Cider, and Nescafe. “

Concert Pharmaceuticals (NASDAQ:CNCE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple tumors, and hyperparathyroidism. Concert Pharmaceuticals Inc. is based in United States. “

Cisco Systems (NASDAQ:CSCO) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Convergys Corporation (NYSE:CVG) had its hold rating reissued by analysts at Robert W. Baird. Robert W. Baird currently has a $28.00 target price on the stock.

CommVault Systems (NASDAQ:CVLT) was downgraded by analysts at UBS AG from an overweight rating to a neutral rating.

Fortune Brands Home & Security (NYSE:FBHS) had its buy rating reissued by analysts at Robert W. Baird. They currently have a $72.00 price target on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its hold rating reissued by analysts at Piper Jaffray Companies. They currently have a $27.00 target price on the stock.

Fulgent Genetic (NASDAQ:FLGT) had its buy rating reiterated by analysts at Piper Jaffray Companies.

FLIR Systems (NASDAQ:FLIR) had its hold rating reissued by analysts at Robert W. Baird. Robert W. Baird currently has a $34.00 price target on the stock.

HealthStream (NASDAQ:HSTM) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $26.00 target price on the stock.

Innoviva (NASDAQ:INVA) had its hold rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $13.00 target price on the stock.

Lennox International (NYSE:LII) had its buy rating reiterated by analysts at Robert W. Baird.

LogMein (NASDAQ:LOGM) had its buy rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $170.00 price target on the stock.

Mercury Systems (NASDAQ:MRCY) had its buy rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $48.00 price target on the stock.

Mulesoft (NASDAQ:MULE) had its buy rating reiterated by analysts at Piper Jaffray Companies.

NanoString Technologies (NASDAQ:NSTG) had its buy rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $14.00 target price on the stock.

Natera (NASDAQ:NTRA) had its buy rating reaffirmed by analysts at Robert W. Baird.

New York Community Bancorp (NYSE:NYCB) had its sell rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $11.00 price target on the stock.

Potlatch Corporation (NASDAQ:PCH) had its price target increased by DA Davidson to $47.00. The firm currently has an underperform rating on the stock.

PROS Holdings (NYSE:PRO) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $35.00 target price on the stock.

Paratek Pharmaceuticals (NASDAQ:PRTK) had its buy rating reiterated by analysts at Robert W. Baird. Robert W. Baird currently has a $40.00 target price on the stock.

Reata Pharmaceuticals (NASDAQ:RETA) had its buy rating reissued by analysts at Robert W. Baird. Robert W. Baird currently has a $47.00 target price on the stock.

Raytheon (NYSE:RTN) had its buy rating reiterated by analysts at Robert W. Baird. The firm currently has a $212.00 target price on the stock.

Steven Madden (NASDAQ:SHOO) had its buy rating reiterated by analysts at Canaccord Genuity. The analysts wrote, “We are positive on SHOO into its Q3 report on Tuesday, October 31 BMO. Excluding the hurricane impact in TX and FL (which we estimate hurt comps by ~100bps), Q3 should be another solid quarter with EPS upside potential of 1-2c due to the strength of core SM women’s. We are currently modeling EPS of 76c vs. 77c consensus on net sales growth of 8%, based on wholesale sales growth of 8.4% and a 2% retail comp. Within the wholesale segment, we are modeling 2.2% growth in core w/s footwear (due to weak private label and tough comparisons in SM women’s) and 3% growth in w/s accessories as we believe handbags have ticked up now that industry promotional pressures have subsided. In addition, we estimate Schwartz & Benjamin (S&B) will add ~$21M (or ~600bps of growth) to Q3 wholesale revenue.””

Silicon Motion Technology Corporation (NASDAQ:SIMO) had its price target raised by Roth Capital from $55.00 to $60.00. They currently have a buy rating on the stock.

Silicon Laboratories (NASDAQ:SLAB) had its price target boosted by Roth Capital from $85.00 to $100.00. The firm currently has a buy rating on the stock.

Seagate Technology PLC (NASDAQ:STX) had its hold rating reissued by analysts at Argus. They currently have a $40.00 price target on the stock.

Tabula Rasa Healthcare (NASDAQ:TRHC) had its buy rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $29.00 price target on the stock.

Tyler Technologies (NYSE:TYL) had its buy rating reaffirmed by analysts at Needham & Company LLC.

Union Bankshares Corporation (NASDAQ:UBSH) had its hold rating reaffirmed by analysts at Brean Capital.

Western Alliance Bancorporation (NYSE:WAL) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $64.50 target price on the stock.

Zions Bancorporation (NASDAQ:ZION) had its hold rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $44.00 target price on the stock.

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.